Bullish Moving Averages
14
Bearish Moving Averages
2
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1780.10Today’s High
1804.0052W low
1137.5052W High
1940.00Open Price
1803.50Prev. Close
1771.1000Volume
93244.00Value
166496486.40Fundamentals
Market Cap Cr
27714.90
Price to Earnings
50.10
Price to Book Value
9.50
Dividend Yield
0.60
PE to Growth
1.40
Op Revenue TTM Cr
3484.18
Net Profit TTM Cr
552.64
Cash From Operating Activity Cr
800.62
Return on Equity %
18.90
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
36.7
Week
26.1
Month
44.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1799.02
PIVOT
First Resistance
1824.33
Second Resistance
1843.52
Third Resistance
1868.83
First Support
1779.83
Second Support
1754.52
Third Support
1735.33
Relative Strength Index
53.14
Money Flow Index
60.34
MACD
-5.7
MACD Signal
-4.88
Average True Range
70.17
Average Directional Index
13.38
Rate of Change (21)
1.29
Rate of Change (125)
11.73
Commodity Channel Index
-6.4
Williams %R
-45.2
BETA
1 Month
0.31
3 Month
0.31
1 Year
0.27
3 Year
0.22
PRICE CHANGE ANALYSIS
↑ 3.53%
1 Week
Low
High
1668.7
1906
↑ 0.2%
1 Month
Low
High
1667.05
1926.85
↑ 6.01%
3 Months
Low
High
1635.5
1926.85
↑ 5.02%
6 Months
Low
High
1480
1940
↑ 51.17%
1 Year
Low
High
1137.5
1940
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 825.30 | 806.71 | 843.60 | 857.71 | 702.44 | 732.05 | 741.68 | 716.64 | 585.43 | 537.59 | 546.29 | |
| Operating Expenses Qtr | 614.15 | 585.41 | 601.92 | 617.75 | 537.70 | 559.45 | 574.17 | 548.15 | 461.99 | 418.93 | 412.04 | |
| Operating Profit Qtr | 195.05 | 214.69 | 234.84 | 234.83 | 161.44 | 169.49 | 165.79 | 167.98 | 121.58 | 114.34 | 114.68 | |
| EBIDT Qtr Cr | 211.15 | 221.30 | 241.68 | 239.96 | 164.74 | 172.60 | 167.51 | 168.49 | 123.44 | 118.65 | 134.24 | |
| Depreciation Qtr | 39.72 | 33.37 | 31.50 | 30.65 | 30.56 | 28.04 | 27.71 | 25.69 | 21.79 | 16.62 | 15.40 | |
| Net Profit Qtr | 125.85 | 127.92 | 145.02 | 144.57 | 88.67 | 101.21 | 97.72 | 101.29 | 82.72 | 74.57 | 88.40 | |
| Basic EPS Qtr | 8.11 | 8.25 | 9.36 | 18.68 | 11.46 | 13.08 | 12.64 | 13.11 | 10.71 | 9.65 | 11.44 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 3333.32 | 2892.81 | 2228.49 | 2003.88 | 1690.09 | |
| Operating Expenses Annual Cr | 2419.22 | 2219.47 | 1680.97 | 1335.63 | 1272.50 | |
| Operating Profit Annual | 879.42 | 664.69 | 508.91 | 556.37 | 368.24 | |
| Operating Profit Margin Annual % | 26.38 | 22.98 | 22.84 | 27.76 | 21.79 | |
| Total Expenses Annual Cr | 2594.98 | 2365.77 | 1757.20 | 1410.18 | 1340.53 | |
| EBIDT Annual Cr | 914.10 | 673.34 | 547.52 | 668.25 | 417.59 | |
| EBIDT Annual margin % | 27.42 | 23.28 | 24.57 | 33.35 | 24.71 | |
| Depreciation | 135.24 | 111.99 | 71.28 | 67.36 | 65.09 | |
| PAT Before ExtraOrdinary Items Annual Cr | 543.36 | 388.89 | 361.00 | 447.08 | 268.14 | |
| Net Profit Annual | 543.36 | 388.89 | 361.00 | 447.08 | 268.14 | |
| Basic EPS Annual | 35.07 | 50.29 | 46.71 | 57.85 | 33.70 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2886.26 | 2442.45 | 2103.67 | 1806.46 | 1445.29 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 206.32 | 519.64 | 87.06 | 86.41 | 73.29 | |
| Total Current Liabilities Annual Cr | 821.06 | 508.03 | 347.34 | 307.56 | 292.43 | |
| Total Capital Plus Liabilities Annual Cr | 3913.64 | 3470.15 | 2538.07 | 2200.43 | 1811.01 | |
| Fixed Assets Annual | 2001.48 | 1876.81 | 1222.34 | 590.17 | 599.37 | |
| Total Non Current Assets Annual | 2183.47 | 2071.85 | 1385.75 | 742.49 | 805.74 | |
| Total Current Assets Annual | 1730.17 | 1398.30 | 1152.31 | 1457.94 | 1005.27 | |
| Total Assets Annual | 3913.64 | 3470.15 | 2538.07 | 2200.43 | 1811.01 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 120.63 | 68.13 | 117.00 | 121.66 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 789.04 | 628.64 | 147.10 | 335.43 | 271.57 | |
| Cash from Investing Activity Annual | -412.45 | -955.88 | 4.18 | -230.68 | 24.18 | |
| Cash from Financing Annual Activity | -374.08 | 343.41 | -137.85 | -86.90 | -305.48 | |
| Net Cash Flow Annual | - | 16.17 | 13.42 | 17.86 | -9.73 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 185.97 | 315.65 | 272.21 | 233.75 | 187.01 | |
| ROE Annual % | 18.82 | 15.92 | 17.16 | 24.74 | 18.55 | |
| ROCE Annual % | 25.18 | 18.95 | 21.73 | 31.74 | 23.21 | |
| Total Debt to Total Equity Annual | 0.12 | 0.22 | 0.01 | 0.01 | 0.02 | |
| EBDIT Annual Margin % | 27.71 | 23.34 | 25.00 | 35.32 | 25.45 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 878.36 | 851.86 | 889.40 | 901.83 | 766.90 | 795.84 | 810.78 | 785.70 | 626.67 | 605.18 | 612.66 | |
| Operating Expenses Qtr | 663.61 | 621.39 | 638.20 | 664.09 | 598.68 | 617.94 | 624.86 | 612.05 | 499.66 | 472.55 | 466.27 | |
| Operating Profit Qtr | 198.12 | 223.12 | 243.54 | 232.11 | 163.64 | 174.77 | 184.58 | 172.76 | 124.92 | 128.11 | 126.74 | |
| EBIDT Qtr Cr | 214.75 | 230.47 | 251.20 | 237.74 | 168.22 | 177.90 | 185.92 | 173.65 | 127.00 | 132.64 | 146.39 | |
| Depreciation Qtr | 40.74 | 34.03 | 32.17 | 31.38 | 31.80 | 28.40 | 28.13 | 26.08 | 22.11 | 16.97 | 15.73 | |
| Net Profit Qtr | 126.16 | 133.57 | 150.59 | 142.32 | 87.63 | 106.10 | 111.08 | 105.03 | 84.84 | 83.89 | 97.75 | |
| Basic EPS Qtr | 8.22 | 8.62 | 9.72 | 18.39 | 11.33 | 13.72 | 14.37 | 13.59 | 10.98 | 10.85 | 12.65 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 3521.45 | 3159.22 | 2463.47 | 2154.90 | 1825.40 | |
| Operating Expenses Annual Cr | 2587.29 | 2453.53 | 1880.79 | 1482.11 | 1397.15 | |
| Operating Profit Annual | 896.89 | 695.75 | 543.46 | 560.41 | 377.57 | |
| Operating Profit Margin Annual % | 25.47 | 22.02 | 22.06 | 26.01 | 20.68 | |
| Total Expenses Annual Cr | 2769.94 | 2603.99 | 1958.57 | 1558.02 | 1466.51 | |
| EBIDT Annual Cr | 934.16 | 705.69 | 582.68 | 672.79 | 428.24 | |
| EBIDT Annual margin % | 26.53 | 22.34 | 23.65 | 31.22 | 23.46 | |
| Depreciation | 138.32 | 114.41 | 72.66 | 68.67 | 66.32 | |
| PAT Before ExtraOrdinary Items Annual Cr | 552.63 | 410.01 | 386.04 | 448.52 | 272.39 | |
| Net Profit Annual | 552.63 | 409.84 | 385.36 | 447.96 | 272.05 | |
| Basic EPS Annual | 34.85 | 53.00 | 49.86 | 57.96 | 34.20 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2923.33 | 2480.33 | 2134.12 | 1809.72 | 1435.49 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 4.49 | 3.71 | 2.50 | |
| Total Non Current Liabilities Annual Cr | 202.57 | 519.07 | 85.07 | 79.41 | 62.72 | |
| Total Current Liabilities Annual Cr | 868.23 | 554.45 | 383.72 | 345.27 | 312.85 | |
| Total Capital Plus Liabilities Annual Cr | 3994.13 | 3553.87 | 2607.40 | 2238.12 | 1813.56 | |
| Fixed Assets Annual | 2023.34 | 1898.70 | 1238.21 | 601.76 | 614.29 | |
| Total Non Current Assets Annual | 2125.79 | 2025.84 | 1332.55 | 685.51 | 740.83 | |
| Total Current Assets Annual | 1868.34 | 1528.03 | 1274.86 | 1552.60 | 1072.73 | |
| Total Assets Annual | 3994.13 | 3553.87 | 2607.40 | 2238.12 | 1813.56 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 148.86 | 68.13 | 121.03 | 121.66 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 800.62 | 625.61 | 170.13 | 314.78 | 275.37 | |
| Cash from Investing Activity Annual | -403.83 | -961.79 | 2.32 | -230.68 | 24.30 | |
| Cash from Financing Annual Activity | -385.48 | 356.54 | -138.39 | -87.42 | -306.05 | |
| Net Cash Flow Annual | - | 20.36 | 34.07 | -3.31 | -6.38 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 188.36 | 320.55 | 276.73 | 234.65 | 186.07 | |
| ROE Annual % | 18.90 | 16.52 | 18.05 | 24.75 | 18.95 | |
| ROCE Annual % | 25.45 | 19.71 | 22.93 | 31.91 | 24.11 | |
| Total Debt to Total Equity Annual | 0.12 | 0.22 | 0.01 | 0.02 | 0.02 | |
| EBDIT Annual Margin % | 26.81 | 22.40 | 24.03 | 32.93 | 24.13 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C AXIS SMALL CAP FUND | 2.7 | 75055017 | - | - |
| CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO SMALL CAP FUND | 1.18 | 75055019 | - | - |
| KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD. | 1 | 75055021 | - | - |
| GOVERNMENT PENSION FUND GLOBAL | 1.59 | 75055026 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| TAU INVESTMENT HOLDINGS PTE. LTD. | 53.78 | 75055013 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND | 3.15 | 75055016 |
| AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C AXIS SMALL CAP FUND | 2.7 | 75055017 |
| INVESCO INDIA CONTRA FUND | 1.21 | 75055018 |
| CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO SMALL CAP FUND | 1.18 | 75055019 |
| GOVERNMENT PENSION FUND GLOBAL | 1.59 | 75055026 |
| KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD. | 1 | 75055021 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 16, 2024 | 5.5 | INTERIM | Feb 16, 2024 | Equity Share |
| Aug 17, 2023 | 9.25 | FINAL | - | Equity Share |
| Feb 17, 2023 | 8.5 | INTERIM | Feb 18, 2023 | Equity Share |
| Aug 12, 2022 | 8 | FINAL | - | Equity Share |
| Feb 23, 2022 | 8.5 | INTERIM | Feb 24, 2022 | Equity Share |
| Sep 01, 2021 | 8 | FINAL | - | Equity Share |
| Feb 18, 2021 | 8.5 | INTERIM | Feb 22, 2021 | Equity Share |
| Sep 22, 2020 | 1 | FINAL | - | Equity Share |
| Mar 03, 2020 | 10 | INTERIM | Mar 04, 2020 | Equity Share |
| Aug 14, 2019 | 5 | FINAL | Aug 16, 2019 | Equity Share |
| Aug 27, 2018 | 2 | FINAL | - | Equity Share |
| Sep 11, 2017 | 1 | FINAL | - | Equity Share |
| Aug 11, 2016 | 0.5 | FINAL | - | Equity Share |
| Mar 17, 2016 | 4.5 | INTERIM | Mar 19, 2016 | Equity Share |
| Aug 06, 2015 | 4 | FINAL | - | Equity Share |
| Aug 06, 2015 | 10 | SPECIAL | - | Equity Share |
| Sep 04, 2014 | 3 | FINAL | - | Equity Share |
| Aug 01, 2013 | 3 | FINAL | - | Equity Share |
| Jul 19, 2012 | 1 | FINAL | - | Equity Share |
| Aug 29, 2011 | 40 | SPECIAL | Aug 31, 2011 | Equity Share |
| Jul 14, 2011 | 2 | FINAL | - | Equity Share |
| Jul 15, 2010 | 2 | FINAL | - | Equity Share |
| Jul 02, 2009 | 1 | FINAL | - | Equity Share |
| Jul 03, 2008 | 0.5 | FINAL | - | Equity Share |
| Jul 12, 2007 | 1.5 | FINAL | - | Equity Share |
| Nov 13, 2006 | 1.1 | INTERIM | Nov 14, 2006 | Equity Share |
| Jun 29, 2006 | 1.5 | FINAL | - | Equity Share |
| Nov 08, 2005 | 1.1 | INTERIM | Nov 09, 2005 | Equity Share |
| Jun 30, 2005 | 1.4 | FINAL | - | Equity Share |
| Nov 11, 2004 | 5 | INTERIM | Nov 16, 2004 | Equity Share |
| Jun 28, 2004 | 6.5 | FINAL | - | Equity Share |
| Nov 13, 2003 | 4.5 | INTERIM | Nov 14, 2003 | Equity Share |
| Jun 30, 2003 | 8 | FINAL | - | Equity Share |
| Jun 26, 2002 | - | FINAL | - | Equity Share |
| Sep 25, 2001 | - | INTERIM | Oct 11, 2001 | Equity Share |
| Jul 16, 2001 | - | FINAL | - | Equity Share |
| Jan 19, 2001 | - | INTERIM | Feb 05, 2001 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Sep 18, 2023 | 2:1 | 2023-09-18 |
| Apr 05, 2005 | 10:2 | 2005-04-12 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 17, 2024 | Audited Results & Final Dividend | - |
| Feb 06, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 07, 2023 | Quarterly Results | - |
| Aug 09, 2023 | Quarterly Results | - |
| May 24, 2023 | Audited Results, Dividend & Stock Split | - |
| Feb 08, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 04, 2022 | Quarterly Results | - |
| May 26, 2022 | Audited Results & Final Dividend | - |
| Feb 14, 2022 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2021 | Quarterly Results | - |
| Aug 12, 2021 | Quarterly Results | - |
| Jun 14, 2021 | Audited Results & Final Dividend | - |
| Apr 01, 2021 | Employees Stock Option Plan | Inter alia, to consider and approve Board meeting intimation for consideration of Employee Stock Option Scheme. |
| Feb 10, 2021 | Quarterly Results | - |
| Nov 10, 2020 | Quarterly Results | - |
| Sep 14, 2020 | Quarterly Results | - |
| Jun 25, 2020 | Audited Results | - |
| Feb 20, 2020 | Interim Dividend | - |
| Feb 04, 2020 | Quarterly Results | - |
| Nov 12, 2019 | Quarterly Results & Buy Back | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 21, 2019 | Audited Results & Dividend | - |
| Feb 08, 2019 | Quarterly Results | - |
| Nov 02, 2018 | Quarterly Results | - |
| Aug 31, 2018 | Buy Back of Shares | - |
| Aug 10, 2018 | Quarterly Results | - |
| May 25, 2018 | Audited Results & Dividend | - |
| Feb 09, 2018 | Quarterly Results | - |
| Nov 10, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 23, 2017 | Audited Results & Dividend | - |
| Feb 10, 2017 | Quarterly Results | - |
| Nov 18, 2016 | Quarterly Results | Appointed Dr. Manoj R. Mashru as additional director of the Company. |
| Aug 26, 2016 | Quarterly Results | - |
| May 20, 2016 | Audited Results & Dividend | - |
| Mar 11, 2016 | Interim Dividend | - |
| Feb 03, 2016 | Quarterly Results | Appointed Mr. Shaukat H. Merchant as an additional director of the Company. He is an independent director on the board. |
| Nov 04, 2015 | Quarterly Results | Approved the acquisition of 21,94,030 (51%) ordinary shares in Biotech Laboratories (Pty.) Ltd., South Africa ("Biotech"), held by Africa Biopharma Investments (Pty.) Ltd. |
| Aug 05, 2015 | Quarterly Results | - |
| May 20, 2015 | Audited Results & Dividend | - |
| Feb 04, 2015 | Quarterly Results | - |
| Nov 10, 2014 | Quarterly Results | - |
| Aug 05, 2014 | Quarterly Results | - |
| May 26, 2014 | Audited Results & Dividend | - |
| Feb 11, 2014 | Quarterly Results | - |
| Oct 30, 2013 | Quarterly Results | - |
| Jul 26, 2013 | Quarterly Results | - |
| May 24, 2013 | Audited Results & Dividend | - |
| Feb 05, 2013 | Quarterly Results | - |
| Nov 01, 2012 | Quarterly Results | - |
| Aug 06, 2012 | Quarterly Results | - |
| May 23, 2012 | Audited Results & Final Dividend | - |
| Apr 18, 2012 | Appointment of Director's | The Board has appointed Mr. Jashvantrai B. Joshi as a Director of the Company & Appointed Mr. Sanjay Asher as an Alternate Director to Mr. Jashvantrai B. Joshi. |
| Jan 25, 2012 | Quarterly Results | - |
| Oct 19, 2011 | Quarterly Results | - |
| Aug 19, 2011 | Special Interim Dividend | - |
| Jul 29, 2011 | Quarterly Results | - |
| Jul 22, 2011 | Others | - |
| May 23, 2011 | Audited Results & Dividend | - |
| Jan 13, 2011 | Quarterly Results | - |
| Oct 26, 2010 | Quarterly Results | - |
| Jul 29, 2010 | Quarterly Results | - |
| May 05, 2010 | Audited Results & Dividend | - |
| Jan 28, 2010 | Quarterly Results | - |
| Oct 26, 2009 | Quarterly Results | - |
| Jul 21, 2009 | Quarterly Results | - |
| May 12, 2009 | Audited Results & Dividend | - |
| Jan 22, 2009 | Quarterly Results | - |
| Oct 20, 2008 | Quarterly Results | - |
| Jul 25, 2008 | Quarterly Results | - |
| Jul 04, 2008 | Buy back of shares | To Buy-Back of the Company's own shares up to the limit specified therein and providing for the ceiling rate at which such Buy-Back may be made. |
| May 08, 2008 | Audited Results & Dividend | - |
| Apr 08, 2008 | Buy Back of Shares | - |
| Jan 29, 2008 | Quarterly Results | - |
| Oct 30, 2007 | Quarterly Results | - |
| Jul 28, 2007 | Quarterly Results | - |
| May 16, 2007 | Audited Results & Final Dividend | - |
| Jan 22, 2007 | Quarterly Results | - |
| Oct 30, 2006 | Quarterly Results & Interim Dividend | - |
| Jul 27, 2006 | Quarterly Results | - |
| May 10, 2006 | Amalgamation | To consider Amalgamation of 'Lekar Healthcare Ltd', Wholly Owned Subsidiary into the Company. |
| Jan 24, 2006 | Quarterly Results & Preferential Issue | - |
| Oct 24, 2005 | Quarterly Results & Interim Dividend | - |
| Jul 28, 2005 | Quarterly Results | (Revised) |
| May 12, 2005 | Accounts & Dividend | - |
| Jan 27, 2005 | Quarterly Results & Others | Sub Division of Equity shares |
| Oct 28, 2004 | Interim Dividend & Quarterly Results | - |
| Jul 28, 2004 | Quarterly Results | - |
| May 07, 2004 | Accounts & Final Dividend | - |
| Feb 19, 2004 | Employees Stock Option Plan | - |
| Jan 28, 2004 | Quarterly Results | - |
| Oct 29, 2003 | Quarterly Results | - |
| Jul 24, 2003 | Quarterly Results | - |
| May 07, 2003 | Dividend & Accounts | - |
| Jan 24, 2003 | Quarterly Results | - |
| Oct 29, 2002 | Quarterly Results | - |
| Jul 26, 2002 | Quarterly Results | - |
| May 07, 2002 | Accounts, Final Dividend & Others | Accounts, Final Dividend & Book-closure of register of members of the company will also considered in the same meeting. |
| Mar 13, 2002 | Second Interim Dividend | (Revised) |
| Jan 24, 2002 | Quarterly Results | - |
| Oct 11, 2001 | Quarterly Results & I. Dividend | - |
| Jul 28, 2001 | Quarterly Results | - |
| Jun 12, 2001 | Accounts & Dividend | - |
| Jan 25, 2001 | Interim Dividend & Quarterly Results | Interim Dividend & Quarterly Results |
| Oct 21, 2000 | Quarterly Results | - |
| Jul 31, 2000 | Quarterly Results | - |
| Jun 16, 2000 | Accounts | - |
| Apr 03, 2000 | Amalgamation | - |
| Mar 03, 2000 | Interim Divdend | - |
| Jan 28, 2000 | Quarterly Results | - |
| Oct 28, 1999 | Q.Results & I.Dividend | - |
| Jul 30, 1999 | Quarterly Results | - |
| May 31, 1999 | Accounts & Final Dividend | - |
| Jan 28, 1999 | Quarterly Results | - |
| Oct 30, 1998 | Interim Dividend & Quarterly Results | - |
| Oct 27, 1998 | Quarterly Results | - |
| Sep 09, 1998 | Others | - |
| Jun 19, 1998 | Accounts, Final Dividend and Bonus | - |
| Jun 18, 1998 | Accounts & Final | - |
| Nov 26, 1997 | Half Yearly Results & | - |
| Nov 25, 1997 | Half Yearly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
03 Jul 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Prior Public Notice for Equity Shareholders of the Company with regards to convening of AGM through Video Conferencing (VC)/ Other Audio Visual Means (OAVM)
01 Jul 2024
Kotak Equities initiates coverage on JB Chemicals with a target price of Rs 2,025
Having primarily grown organically until FY2022 and later on aided by benefits from acquired brands, JB has handsomely outperformed the IPM in the past decade by ~600 bps and currently ranks 22 in the IPM, said Alankar Garude, Analyst at Kotak Equities.
26 Jun 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Closure of Trading Window
Intimation of Trading Window closure period
12 Jun 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Submission of Information of loss of share certificate
07 Jun 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Intimation Of Schedule Of Analysts/Institutional Investors Meet
Intimation of schedule of Analysts/Institutional investors meet
06 Jun 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for Postal Ballot
05 Jun 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice
04 Jun 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme
03 Jun 2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Recommendation Of Appointment Of Director
Recommendation of appointment of Director
30 May 2024
JB Chemicals looks to double revenue with expansion in the domestic market
Analyst at ICICI Securities expecting revenue contributions from India and CMO businesses to rise from 67% to 75%
